Exhibit 5.1
| | | | | | |
April 27, 2023 | | | | | | ![LOGO](https://capedge.com/proxy/S-3/0001193125-23-122390/g406168g0425085256000.jpg) |
| | | | | | Orrick, Herrington & Sutcliffe LLP |
| | | | | | 222 Berkeley St. |
Local Bounti Corporation | | | | | | Ste. 2000 |
400 W. Main St. | | | | | | Boston, MA 02116 |
Hamilton, MT 59840 | | | | | | +1-617-880-1800 |
| | | | | | orrick.com |
| | | | | | |
| | | | | | |
Re: | Local Bounti Corporation |
Registration Statement on Form S-3
Ladies and Gentlemen:
We have acted as counsel to Local Bounti Corporation, a Delaware corporation (the “Company”), in connection with the filing by the Company of a Registration Statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”), including a related prospectus filed with the Registration Statement (the “Prospectus”), covering the resale of up to 69,600,000 shares (the “2023 Warrant Shares”) of Company common stock, par value $0.0001 per share (the “Common Stock”), that are issuable by the Company upon the exercise of 69,600,000 warrants (the “2023 Warrants”), pursuant to that certain Common Stock Purchase Warrant, dated as of March 28, 2023 (the “Warrant”), issued by the Company to that certain selling securityholder (the “Selling Securityholder”) named in the Registration Statement, which may be offered and sold from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). All of the 2023 Warrants Shares are being registered on behalf of the Selling Securityholder.
In connection with this opinion, we have examined and relied upon (i) the Registration Statement and the Prospectus; (ii) the Company’s certificate of incorporation, as amended, and bylaws, each as currently in effect; (iii) the Warrant; and (iv) originals or copies, certified or otherwise, identified to our satisfaction, of such corporate records of the Company, such certificates of public officials, officers of the Company and other persons, and such other documents, agreements and instruments as we have deemed relevant and necessary for the purpose of rendering our opinion set forth below.
In such examination, we have assumed the following: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity to the originals of all documents submitted to us as copies; (iii) the legal competence of all signatories to such documents; and (iv) the truth, accuracy, and completeness of the information, factual matters, representations and warranties contained in the records, documents, instruments, and certificates we have reviewed.
With respect to the 2023 Warrants and the 2023 Warrant Shares, we express no opinion to the extent that, notwithstanding the Company’s current reservation of shares of Common Stock, future issuances of securities of the Company, including the 2023 Warrant Shares, and/or antidilution adjustments to outstanding securities of the Company, including the 2023 Warrants, may cause the 2023 Warrants to be exercisable for more shares of Common Stock than the number that then remain authorized but unissued. Further, we have assumed the Exercise Price (as defined in the Warrant) will not be adjusted to an amount below the par value per share of the shares of Common Stock.